Biogen Message Board - Msg: 5074845

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen

BIIB 181.89

0.0%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Harold Engstrom who wrote (684)	7/1/1998 1:45:00 PM
From: Hong-Lee Yu	Read Replies (1) of 1686

Harold, I don't. IMHO, any pipeline news to increase the visibility of year 2000-2001 and beyond is going to be very helpful - allows BGEN to trade at a premium above the growth rate. Genesis Merchant Group Securities initiated coverage of Biogen, Inc. (Nasdaq: BGEN - news) with a buy recommendation and a target price of $58 per share. biz.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next